Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Belgium

Belgium Articles

Companies

As part of a restructuring programme for its European operations, US firm Eli Lilly has simultaneously closed its R&D facility in Belgium and announced the construction of biopharmaceutical... 2006-12-05


Companies

The Belgium government has finalised the health insurance budget for next year, ensuring that more people on low incomes will receive a larger rebate on doctors' fees and medicine... 2006-11-07


Companies

To enter the expanding Central and Eastern Europe over-the-counter (OTC) medicines market, Belgian firm Omega Pharma has acquired Austrian consumer healthcare company Bittner Pharma.... 2006-10-26


Companies

Continuing the consolidation trend in the European pharmaceutical sector, Belgian firm UCB has unveiled a EUR4.4bn (US$5.6bn) bid for German company Schwarz Pharma to create major... 2006-10-04


Companies

In a victory for small, innovative biotechnology companies, a US federal jury has awarded Belgian biotech firm Innogenetics US$7mn in damages after determining that US-based Abbott... 2006-09-18


Companies

Matching compatriot firm Solvay, Belgian drugmaker UCB has released strong financial results for the first half of 2006 in which revenues increased by 12% to EUR1.3bn (US$1.7bn).... 2006-08-02


Companies

On the back of robust first half of 2006 financial results, Belgian pharmaceutical and chemical group Solvay intends to expand its reach in its faster growing markets, specifically... 2006-08-02


Companies

Belgium firm UCB Pharma has revealed plans to again make a sustained effort to sell its products in the booming Russia pharmaceutical market. Currently, the company distributes a... 2006-07-25


Companies

Canadian Firm Labopharm has granted Belgium distribution rights covering its once-daily formulation of the painkiller tramadol to German company Grunenthal. Labopharma will supply... 2006-05-12


Industry

Belgium pharmaceutical, plastics and chemicals group Solvay is seeking critical mass in its drugs division to ensure future prosperity, following the release of impressive Q106 financial... 2006-05-10

11 to 20 of 22 results
<< | < | 1 | 2 | 3 | > | >>
Insight